Scandinavian Real Heart

In the presentation, CEO Ina Laura Perkins gives an overview of the company's operations, technology platform, and strategic direction going forward. Parts of the presentation also touch on the rights issue that the company has previously communicated, the subscription period for which began yesterday, January 13, 2026. The rights issue closes on January 27.

Ina Laura also demonstrates today's existing artificial heart systems and highlights their limitations from a patient perspective. She compares these with Realheart's patient-centered solution—a heart designed to mimic the natural blood flow of the human heart and an external patient unit that is quiet, lightweight, and has a long battery life. All this is done to create the best conditions for long-term treatment of patients with severe heart failure.

As previously announced, the purpose of the issue is to finance the continued development of Realheart's artificial heart Realheart® TAH and to strengthen the company's financial position ahead of upcoming development and regulatory steps. Full terms and conditions for the issue, including the subscription period, use of issue proceeds, and other details, are set out in previous press releases.

Read more and subscribe here: https://realheart.se/preferential-rights-issue-realheart/

A recording of the presentation* is available on the Company's YouTube channel: https://youtu.be/AaaZkgmn4GM

* The presentation is in Swedish.